Acute damage to the central nervous system due to stroke, seizure disorders, and trauma are very common, and these problems are the most frequent neurologic causes of death and disability. It has been thought that several pathological molecular mechanisms are present in all of these disorders. In the past there have been few attempts to systematically study these precise relationships in a coordinated fashion. Previously, much attention was focussed on abnormalities of energy metabolism and blood flow. There can be little doubt that these factors are of considerable importance, but it is probable that they are not the sole causes of irreversible damage and play a relatively minor part in whatever recovery of function occurs. Our contention is that there are rapid alterations in protein structure and function in response to acute CNS insults that are critical to maintenance and restoration of neurologic integrity. Consequently, we have designed a program to investigate the similarities and differences in degenerative and regenerative responses to a variety of acute neurological insults. We will use 4 types of systems to model CNS injury: 1) surgical lesions in the fimbria-fornix pathway; 2) a seizure model produced by a lesion in this same area; 3) in vivo ischemia models; 4) a tissue culture ischemia model. The studies will consist of detailed examinations of the changes in protein phosphorylation, molecular genetics, and growth factors that occur a times of interest after the injury. We will also correlate physiological, histological, and behavioral alterations during the degenerative and recovery phases. Finally, we will use these initial observations to help us develop a framework for selection of therapies with transplants or pharmacological agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
1P01NS028121-01A1
Application #
3100319
Study Section
Neurological Disorders Program Project Review A Committee (NSPA)
Project Start
1990-08-01
Project End
1993-11-30
Budget Start
1990-08-01
Budget End
1991-11-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Maher, Pamela (2014) Proteasome Assay in Cell Lysates. Bio Protoc 4:
Brennand, K J; Simone, A; Tran, N et al. (2012) Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry 17:1239-53
Brennand, Kristen J; Simone, Anthony; Jou, Jessica et al. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-5
Brennand, Kristen J; Gage, Fred H (2011) Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. Stem Cells 29:1915-22
Maher, Pamela (2008) Proteasome inhibitors prevent oxidative stress-induced nerve cell death by a novel mechanism. Biochem Pharmacol 75:1994-2006
Maher, Pamela (2008) The flavonoid fisetin promotes nerve cell survival from trophic factor withdrawal by enhancement of proteasome activity. Arch Biochem Biophys 476:139-44
Maher, Pamela; Salgado, Karmen F; Zivin, Justin A et al. (2007) A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res 1173:117-25
Shackelford, Deborah A; Yeh, Richard Y (2006) Modulation of ERK and JNK activity by transient forebrain ischemia in rats. J Neurosci Res 83:476-88
Shackelford, Deborah A (2006) DNA end joining activity is reduced in Alzheimer's disease. Neurobiol Aging 27:596-605
Lapchak, Paul A (2006) Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits. Brain Res 1088:141-7

Showing the most recent 10 out of 142 publications